CROHNS DISEASE TREATMENT News, Sports, Shopping, Travel information

Looking for Crohns Disease Treatment?
Find it NOW on NeXplore.com! The New Web 2.0 Search Engine!
www.nexplore.com

Centocor/johnson & Johnson: Sonic Trial Results Support Remicade
remicade has been found to control crohns disease more effectively than azathioprine monotherapy, supporting earlier use of the drug in the treatment algorithm, especially in immunosuppressant- and biologic-naive patients. however, while physicians may need to see such data translated into clear cost-effectiveness, remicade will also face increasing competition from humira and cimzia.
www.pharmaceutical-business-review.com

Infliximab-based Treatment Effective For Crohn's Patients - Businessweek
thursday, oct. 9 (healthday news) -- infliximab (remicade) alone or in combination with azathioprine is more effective in treating crohn's disease than azathioprine alone, researchers report. crohn's disease is an inflammatory disorder of the ...
www.businessweek.com

Cimzia ® Provides Long-term Benefit Without Dose Escalation In Crohn ... - Market Wire
burlington, ontario--(marketwire - oct. 8, 2008) - ucb pharma canada today announced data presented at the american college of gastroenterology (acg) scientific meeting, in orlando, florida, from two studies demonstrating that cimzia ® (certolizumab ...
www.marketwire.com

Cimzia(r) (certolizumab Pegol) Provides Long-term Benefit Without Dose ... - Medical News Today
data from two studies presented this week by ucb at the american college of gastroenterology (acg) annual meeting demonstrate that cimzia (r) (certolizumab pegol) - the only pegylated anti-tnf alpha (tumor necrosis factor alpha) - provides sustained ...
www.medicalnewstoday.com

Surgery Set Tomorrow On Menino's Bum Knee - Boston Globe
talk about taking one for the team. mayor thomas m. menino is scheduled to undergo arthroscopic knee surgery tomorrow to repair cartilage torn when he slipped during a red sox championship rally last fall. months of physical therapy failed to heal ...
www.boston.com

Crohn’s Patients Gain Quality Of Life With New Treatment Plan - Medheadlines.com
researchers at the mayo clinic say the new therapeutic approach to crohn’s disease they’ve developed brings more “opportunity for remission” and “significant improvement in quality of life” for the 500,000 americans estimated to have this ...
medheadlines.com

Outlook For Crohn's Disease Improves Thanks To New Therapies - Science Daily
sciencedaily (oct. 10, 2008) — a study led by mayo clinic has found that infliximab (remicade®) administered alone (monotherapy) or in combination with azathioprine is a more effective treatment for patients with moderate to severe crohn's disease ...
www.sciencedaily.com

Crohn's Disease Or Ulcerative Colitis? - Healthcentral.com
crohn's disease and ulcerative colitis are the two common types of inflammatory bowel disease. they are similar in symptoms, presentation and treatment but have some distinctive characteristics. test your ibd iq and see if you can tell the difference ...
www.healthcentral.com

Flushing Out The Facts About Colonic Irrigation - Newsday
a friend recently told me she was getting colonic irrigation. she is generally healthy but had been feeling rundown. after three sessions, she felt much more energetic and believes that the treatment removes toxins from her body. is this true? is ...
www.newsday.com

Adalimumab Reduces Hospitalization, Major Surgery For Crohn's Disease ... - Medscape News
physicians - maximum of 0.25 ama pra category 1 credit(s) ™ for physicians; family physicians - up to 0.25 aafp prescribed credit(s) for physicians to participate in this internet activity: (1) review the target audience, learning objectives, and ...
www.medscape.com

Infliximab Alone And In Combination Appears More Effective In Treating ... - Medscape News
physicians - maximum of 0.25 ama pra category 1 credit(s) ™ for physicians; family physicians - up to 0.25 aafp prescribed credit(s) for physicians to participate in this internet activity: (1) review the target audience, learning objectives, and ...
www.medscape.com